KPJ HEALTHCARE BHD

KLSE (MYR): KPJ (5878)

You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!

Last Price

1.18

Today's Change

+0.02 (1.72%)

Day's Change

1.15 - 1.18

Trading Volume

7,679,400

Company Announcement


Date Subject
Discussions
4 people like this. Showing 50 of 1,813 comments

ElijahYH

A better-than-expected recovery in patient volume and operational efficiency is bolstering KPJ Healthcare Bhd's prospects, even as it comes off a stellar set of financial results.

KPJ reported a core profit after tax and minority interest (Patami) of RM54.6mil in Q3, which was double that of the immediate preceding quarter.

The healthcare group declared an interim dividend of one sen, going ex on Dec 12, 2022, as compared with a payout of 0.3 sen in the same quarter last year.

According to Hong Leong Investment Bank (HLIB) Research, the results were above its and consensus expectations at 95% of full-year forecasts.

2022-11-24 14:14

ElijahYH

"The stellar results were achieved mainly due to stronger-than-expected recovery in hospital operations post-pandemic.

"We raise our FY22-24f earnings forecasts by 20-36%, to better reflect the strong rebound in patient volume and operational efficiency," said the research firm in a note.

It reiterated its "buy" call on KPJ while raising its target price to RM1.27 from RM1.13 previously.

2022-11-24 14:14

ElijahYH

"The debt repayment is expected to lower KPJ’s net gearing to 0.61x, from 0.68x. The proposed sale is expected to complete by 1Q23," said HLIB.

In a separate report, CGS-CIMB Research noted that patient volume and bed occupancy rates have surpassed even pre-pandemic levels, possibly owing to underlying demand and pent-up demand from patients who had deferred surgeries during the COvid lockdowns.

"Post-3Q22 results, we raise FY22-24 forecast core earnings per share by 8.6-27.4%, mainly to factor in lower opex and depreciation, as well as higher associates earnings.

"We raise our FY22-24F payout ratio assumption to 70%, leading to yields of 2.5-3%.

"Our target price rises to RM1.18, after our earnings upgrade and rolling over to 2024 forecast price-earnings of 32 times (still 10-year mean)," it added.

2022-11-24 14:14

Lightofheaven

bullet ready..KPJ all the way go beyond rm1.00
Happy New year 2023

2022-12-15 11:37

Junqi

Any political appointee in kpj?

2023-01-01 13:19

DickyMe

Wrong question!
Any high quality doctors there?
Currently many are being doctors for the status and remuneration without knowing the work of a doctor.

2023-01-01 13:27

StartOfTheBull

Through my own experience, never trust a doctor 100%, because they are human too.
Avoid abusing our own health is the best medicine and prevention from falling sick.

2023-01-01 13:52

rohank71

TPG

2023-01-12 14:01

Lightofheaven

well done...TP 1.08
KPJ gogogo

2023-01-13 09:40

rohank71

bad company can't even go up

2023-01-25 18:44

bowman

Government hospitals now lack manpower and good service. Private hospitals like this one, with a huge private sector base (this being on panels of most multinationals and GLCs), should do well by default.

2023-02-08 09:33

rohank71

privatise?

2023-02-14 11:23

nicholas99

walao.. privatise more expensive..

2023-02-14 11:23

rohank71

better Johor Corp buy back all the shares and delist this company

2023-02-14 11:23

yu_kaneshiro

another good quarter is coming!

2023-02-14 15:44

hoplanner

yu, how good

2023-02-15 15:45

Money122

.

2023-02-16 10:28

Money122

Can go to rm1.30?

2023-02-16 10:29

NoTimeToTrade

First target for me is RM1.145, if hit, means can go higher after retrace.

2023-02-16 11:17

bowman

Tomorrow may not be good. Sellers dominate today

2023-02-16 22:38

bowman

That's why the market already factored this in from 0.90 to 1.07

2023-02-18 12:57

BursaKakis

Reiterate Add with a 12% higher TP of RM1.32

We raise FY23F/24F core EPS by 18%/16% to factor in lower opex and other
housekeeping adjustments post-FY22 results. Following our earnings upgrade, we raise
KPJ’s TP by 12% to RM1.32, based on an updated CY24F P/E of 31x (10-year mean, vs.
32x previously). While share price rose 34% from its 1-year low at end-Sep 22, its FY23F
P/E of 26.2x is still 17% (0.5 s.d.) below its 10-year historical mean. Potential re-rating
catalysts: full earnings recovery, rising health tourism contributions and improving ROIC.
Key downside risks: severe Covid-19 waves and longer gestation for its new hospitals.

CgsCimb 18/2/2023

2023-02-20 06:42

Silent 88888

1.15 big resistance need big shark come in

2023-02-20 14:47

bowman

Institutional buying mostly, buyers' market. TP1.25 should be in hand within next week, quickest this week

2023-02-20 15:07

hisyam

TP this week 1.20 - 1.25

2023-02-20 17:02

bbc99

My view is they wanna keep the price low so they can privatise low price

2023-02-21 16:48

bowman

Signals are there to test new range - 1.20

2023-02-22 11:24

hoplanner

bowman, it’s nice to hear 1.25, shiok sendiri.....

2023-02-22 14:14

bbc99

When qr out, a lot of people buy and somehow there are people press down the price, why? There must be something fishy

2023-02-23 14:08

NoTimeToTrade

Nothing fishy la, its normal for investors and traders to take profit after such a big run. It also means you get a chance to buy or add more.

2023-02-23 14:29

rohank71

keep price low to buy up all the shares. that's JCorps plan via a GO later. looooong term hold

2023-02-27 00:09

rohank71

wait for next Q for any upside. another 3 mths wait.

2023-02-27 00:09

Thinkcarefully

JCORP is not buying KPJ shares.If it does it has to announce to Bursa.

2023-02-27 15:44

hoplanner

1.25?

2023-02-27 16:48

NoTimeToTrade

@Thankcarefully is right, but unfortunately people love to trade on rumour rather than facts. Anyway need to thank these people for selling low then buying back at high price.

2023-02-27 16:53

Up_down

EPF plays yoyo game and preventing share price from going wild. .

2023-03-05 14:48

hoplanner

1.25?

2023-03-06 15:58

Up_down

KPJ still got legs to move up further in comparison with IHH &TMCLife.

2 months ago

EVEBITDA

Q1 is always supossed to b lower bz in healthcare. dont b surprised this time is different.

2 weeks ago

speakup

Buy Alaqar better. 2¢ dividend every 3 months. Alaqar owns all the hospitals assets of KPJ

2 weeks ago

speakup

KPJ operate the hospitals then pay Alaqar for using the hospitals building

2 weeks ago

EVEBITDA

alaqar is great for passive investors. steady DV but growth capped. still a buy for long term passive holders.

2 weeks ago

EVEBITDA

with better results end of may, kpj will be rerated higher by most analyst. expect a 10 to 15% rerating higher.

2 weeks ago

speakup

Alaqar is a dividend counter not a growth counter

2 weeks ago

bilisinvestor

Institutional investors keep buying. Something brewing?

1 week ago

triplex3mob

Buy buy buy

2 days ago

Win1976

One of the most consistent stocks at lower price at the moment

2 days ago

Post a Comment